![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
A Phase 2 Study of BMS-986036 (PegylatedFGF21) in Obese Adults with Type 2 Diabetes and a High Prevalence of Fatty Liver
|
|
|
Reported by Jules Levin
The Liver Meeting, American Association for the Study of Liver Diseases (AASLD 2016)Boston, Massachusetts, November 11-15, 2016
Edgar D. Charles,1Brent A. Neuschwander-Tetri,2Yi Luo,1
ChunyuKate Wu,1Rose Christian1
1Bristol-Myers Squibb, Lawrenceville, NJ; 2Saint Louis University, St. Louis, MO
![1214161](../images/121416/121416-15/1214161.gif)
![1214162](../images/121416/121416-15/1214162.gif)
![1214163](../images/121416/121416-15/1214163.gif)
![1214164](../images/121416/121416-15/1214164.gif)
![baselineChar](../images/121416/121416-15/baselineChar.gif)
![1214165](../images/121416/121416-15/1214165.gif)
![1214166](../images/121416/121416-15/1214166.gif)
![1214167](../images/121416/121416-15/1214167.gif)
![1214168](../images/121416/121416-15/1214168.gif)
![1214169](../images/121416/121416-15/1214169.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|